Literature DB >> 6995344

Role of complement in chemotaxis: study of a localized infection.

D M Wilson, D J Ormrod, T E Miller.   

Abstract

A model of Escherichia coli-induced pyelonephritis was used to study the effect of complement depletion in an organ-specific, nonimmunological inflammatory lesion in rats. In this model of a local infection, which can be considered to be nonspecific inflammatory stimulus, the depletion of complement by the administration of a purified cobra venom factor did not alter the course of the disease. There were minor differences when the results from complement-depleted and normocomplementemic animals were compared, but the composition of the inflammatory infiltrate was not greatly altered. Therefore, the presence of C3 and a functional complement system are relatively unimportant factors in determining the characteristics of the inflammatory response in a localized infection-induced lesion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995344      PMCID: PMC551066          DOI: 10.1128/iai.29.1.8-12.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Comparison of subcutaneous and intraperitoneal staphylococcal infections in normal and complement-deficient mice.

Authors:  C S Easmon; A A Glynn
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

2.  The effect of complement depletion on lung clearance of bacteria.

Authors:  G N Gross; S R Rehm; A K Pierce
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

3.  Susceptibility of C5-deficient mice to listeriosis: modulation by Concanavalin A.

Authors:  D A Lawrence; R F Schell
Journal:  Cell Immunol       Date:  1978-09       Impact factor: 4.868

4.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

5.  Experimental pyelonephritis: a new method for inducing pyelonephritis in the rat.

Authors:  T E Miller; K B Robinson
Journal:  J Infect Dis       Date:  1973-03       Impact factor: 5.226

6.  Leucocyte mobilizing factor: a new biological activity derived from the third component of complement.

Authors:  K Rother
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

7.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

9.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

10.  Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.

Authors:  J A Jarvinen; A P Dalmasso
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

View more
  3 in total

1.  Early clearance of pneumococci from the lungs of decomplemented rats.

Authors:  S R Rehm; J D Coonrod
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 2.  The inflammatory response and tissue damage. The example of renal scars following acute renal infection.

Authors:  M P Glauser; P Meylan; J Bille
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

3.  Kinetics of acute inflammation induced by Escherichia coli in rabbits. II. The effect of hyperimmunization, complement depletion, and depletion of leukocytes.

Authors:  M M Kopaniak; H Z Movat
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.